Quantitative physiological and morphological aspects of microvascular permeability changes induced by histamine and inhibited by terbutaline.
D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects*; D002610:Cheek; D006224:Cricetinae; D003911:Dextrans / Q000378:metabolism; D004285:Dogs; D005260:Female; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives*; D005452:Fluoresceins / Q000378:metabolism; D005456:Fluorescent Dyes / Q000378:metabolism; D006614:Hindlimb; D006632:Histamine / Q000494:pharmacology*; D007261:Infusions, Intra-Arterial; D008196:Lymph / Q000032:analysis / Q000502:physiology; D046911:Macromolecular Substances; D008297:Male; D008647:Mesocricetus; D008833:Microcirculation / Q000187:drug effects*; D011506:Proteins / Q000032:analysis; D013726:Terbutaline / Q000494:pharmacology*; D014699:Venules / Q000187:drug effects
D003911:Dextrans; D005452:Fluoresceins; D005456:Fluorescent Dyes; D046911:Macromolecular Substances; D011506:Proteins; C015219:fluorescein isothiocyanate dextran; D006632:Histamine; D016650:Fluorescein-5-isothiocyanate; D013726:Terbutaline